Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

被引：300

作者：

Krug, Karsten ^{[1
]}

Jaehnig, Eric J. ^{[2
,3
]}

Satpathy, Shankha ^{[1
]}

Blumenberg, Lili ^{[4
,5
]}

Karpova, Alla ^{[6
]}

Anurag, Meenakshi ^{[2
,3
]}

Miles, George ^{[2
,3
]}

Mertins, Philipp ^{[1
,7
,8
]}

Geffen, Yifat ^{[1
]}

Tang, Lauren C. ^{[1
,9
]}

Heiman, David, I ^{[1
]}

Cao, Song ^{[6
]}

Maruvka, Yosef E. ^{[1
]}

Lei, Jonathan T. ^{[2
,3
]}

Huang, Chen ^{[2
,3
]}

Kothadia, Ramani B. ^{[1
]}

Colaprico, Antonio ^{[10
]}

Birger, Chet ^{[1
]}

Wang, Jarey ^{[11
,12
]}

Dou, Yongchao ^{[2
,3
]}

Wen, Bo ^{[2
,3
]}

Shi, Zhiao ^{[2
,3
]}

Liao, Yuxing ^{[2
,3
]}

Wiznerowicz, Maciej ^{[13
,14
]}

Wyczalkowski, Matthew A. ^{[6
]}

Chen, Xi Steven ^{[10
]}

Kennedy, Jacob J. ^{[15
]}

Paulovich, Amanda G. ^{[15
]}

Thiagarajan, Mathangi ^{[16
]}

Kinsinger, Christopher R. ^{[17
]}

Hiltke, Tara ^{[17
]}

Boja, Emily S. ^{[17
]}

Mesri, Mehdi ^{[17
]}

Robles, Ana, I ^{[17
]}

Rodriguez, Henry ^{[17
]}

Westbrook, Thomas F. ^{[11
,12
]}

Ding, Li ^{[6
]}

Getz, Gad ^{[1
,18
]}

Clauser, Karl R. ^{[1
]}

Fenyo, David ^{[19
]}

Ruggles, Kelly, V ^{[4
,5
]}

Zhang, Bing ^{[2
,3
]}

Mani, D. R. ^{[1
]}

Carr, Steven A. ^{[1
]}

Ellis, Matthew J. ^{[2
,3
]}

Gillette, Michael A. ^{[1
,20
]}

机构：

[1] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA

[2] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA

[3] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA

[4] NYU, Grossman Sch Med, Inst Syst Genet, New York, NY 10016 USA

[5] NYU, Grossman Sch Med, Dept Med, New York, NY 10016 USA

[6] Washington Univ, Dept Med & Genet, Siteman Canc Ctr, St Louis, MO 63110 USA

[7] Max Delbruck Ctr Mol Med Helmholtz Soc, Berlin, Germany

[8] Berlin Inst Hlth, Berlin, Germany

[9] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA

[10] Univ Miami, Miller Sch Med, Div Biostat, Dept Publ Hlth Sci, Miami, FL 33136 USA

[11] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Dept Mol & Human Genet, Houston, TX 77030 USA

[12] Baylor Coll Med, Therapeut Innovat Ctr, Houston, TX 77030 USA

[13] Poznan Univ Med Sci, PL-61701 Poznan, Poland

[14] Int Inst Mol Oncol, PL-60203 Poznan, Poland

[15] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA

[16] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA

[17] NCI, Off Canc Clin Prote Res, Bethesda, MD 20892 USA

[18] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02114 USA

[19] NYU, Grossman Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA

[20] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA 02114 USA

来源：

CELL | 2020年 / 183卷 / 05期

关键词：

QUANTITATIVE PROTEOMICS; INTEGRATIVE ANALYSIS; PANCREATIC-CANCER; SOMATIC MUTATIONS; CELL-CYCLE; EXPRESSION; REVEALS; GENOME; ACETYLATION; GENES;

D O I：

10.1016/j.cell.2020.10.036

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The integration of mass spectrometry-based proteomics with next-generation DNA and RNA sequencing profiles tumors more comprehensively. Here this "proteogenomics" approach was applied to 122 treatment-naive primary breast cancers accrued to preserve post-translational modifications, including protein phosphorylation and acetylation. Proteogenomics challenged standard breast cancer diagnoses, provided detailed analysis of the ERBB2 amplicon, defined tumor subsets that could benefit from immune checkpoint therapy, and allowed more accurate assessment of Rb status for prediction of CDK4/6 inhibitor responsiveness. Phosphoproteomics profiles uncovered novel associations between tumor suppressor loss and targetable kinases. Acetyl proteome analysis highlighted acetylation on key nuclear proteins involved in the DNA damage response and revealed cross-talk between cytoplasmic and mitochondrial acetylation and metabolism. Our results underscore the potential of proteogenomics for clinical investigation of breast cancer through more accurate annotation of targetable pathways and biological features of this remarkably heterogeneous malignancy.

引用

页码：1436 / +

页数：52

共 50 条

[1] Oncogenic Mutations in Tumorigenesis and Targeted Therapy in Breast Cancer
Brijesh Kumar
Vaibhav Chand
Anupama Ram
Darksha Usmani
Naoshad Muhammad
Current Molecular Biology Reports, 2020, 6 (3) : 116 - 125
[2] Proteogenomic Landscape of Prospectively Collected Breast Cancer
Gillette, M.
Krug, K.
Satpathy, S.
Jaehnig, E.
Karpova, A.
Clauser, K.
Tang, L.
Blumenberg, L.
Kothadia, R.
Ruggles, K.
Zhang, B.
Ding, L.
Mertins, P.
Mani, D. R.
Ellis, M.
Carr, S.
CANCER RESEARCH, 2020, 80 (04)
[3] Breast cancer quantitative proteome and proteogenomic landscape
Johansson, Henrik J.
Socciarelli, Fabio
Vacanti, Nathaniel M.
Haugen, Mads H.
Zhu, Yafeng
Siavelis, Ioannis
Fernandez-Woodbridge, Alejandro
Aure, Miriam R.
Sennblad, Bengt
Vesterlund, Mattias
Branca, Rui M.
Orre, Lukas M.
Huss, Mikael
Fredlund, Erik
Beraki, Elsa
Garred, Oystein
Boekel, Jorrit
Sauer, Torill
Zhao, Wei
Nord, Silje
Hoglander, Elen K.
Jans, Daniel C.
Brismar, Hjalmar
Haukaas, Tonje H.
Bathen, Tone F.
Schlichting, Ellen
Naume, Bjorn
Geisler, Juergen
Hofvind, Solveig
Engebraten, Olav
Geitvik, Gry Aarum
Langerod, Anita
Karesen, Rolf
Maelandsmo, Gunhild Mari
Sorlie, Therese
Skjerven, Helle Kristine
Park, Daehoon
Hartman-Johnsen, Olaf-Johan
Luders, Torben
Borgen, Elin
Kristensen, Vessela N.
Russnes, Hege G.
Lingjaerde, Ole Christian
Mills, Gordon B.
Sahlberg, Kristine K.
Borresen-Dale, Anne-Lise
Lehtio, Janne
NATURE COMMUNICATIONS, 2019, 10 (1)
[4] Breast cancer quantitative proteome and proteogenomic landscape
Henrik J. Johansson
Fabio Socciarelli
Nathaniel M. Vacanti
Mads H. Haugen
Yafeng Zhu
Ioannis Siavelis
Alejandro Fernandez-Woodbridge
Miriam R. Aure
Bengt Sennblad
Mattias Vesterlund
Rui M. Branca
Lukas M. Orre
Mikael Huss
Erik Fredlund
Elsa Beraki
Øystein Garred
Jorrit Boekel
Torill Sauer
Wei Zhao
Silje Nord
Elen K. Höglander
Daniel C. Jans
Hjalmar Brismar
Tonje H. Haukaas
Tone F. Bathen
Ellen Schlichting
Bjørn Naume
Torben Luders
Elin Borgen
Vessela N. Kristensen
Hege G. Russnes
Ole Christian Lingjærde
Gordon B. Mills
Kristine K. Sahlberg
Anne-Lise Børresen-Dale
Janne Lehtiö
Nature Communications, 10
[5] Breast cancer quantitative proteome and proteogenomic landscape
Johansson, Henrik J.
Socciarelli, Fabio
Vacanti, Nathaniel M.
Haugen, Mads H.
Zhu, Yafeng
Siavelis, Ioannis
Fernandez-Woodbridge, Alejandro
Aure, Miriam R.
Sennblad, Bengt
Vesterlund, Mattias
Branca, Rui M.
Orre, Lukas M.
Huss, Mikael
Fredlund, Erik
Beraki, Elsa
Garred, Oystein
Boeke, Jorrit
Sauer, Torill
Zhao, Wei
Nord, Silje
Hoglander, Elen K.
Jans, Daniel C.
Brismar, Hjalmar
Haukaas, Tonje H.
Bathen, Tone F.
Schlichting, Ellen
Naume, Bjorn
Luders, Torben
Borgen, Elin
Kristensen, Vessela N.
Russnes, Hege G.
Lingjaerde, Ole Christian
Mills, Gordon B.
Sahlberg, Kristine K.
Borresen-Dale, Anne-Lise
Lehtio, Janne
MOLECULAR & CELLULAR PROTEOMICS, 2019, 18 (08) : S40 - S40
[6] Mitochondria in cancer: in the aspects of tumorigenesis and targeted therapy
Badrinath, Narayanasamy
Yoo, So Young
CARCINOGENESIS, 2018, 39 (12) : 1419 - 1430
[7] The Proteogenomic Landscape of Curable Prostate Cancer
Sinha, Ankit
Huang, Vincent
Livingstone, Julie
Wang, Jenny
Fox, Natalie S.
Kurganovs, Natalie
Ignatchenko, Vladimir
Fritsch, Katharina
Donmez, Nilgun
Heisler, Lawrence E.
Shiah, Yu-Jia
Yao, Cindy Q.
Alfaro, Javier A.
Volik, Stas
Lapuk, Anna
Fraser, Michael
Kron, Ken
Murison, Alex
Lupien, Mathieu
Sahinalp, Cenk
Collins, Colin C.
Tetu, Bernard
Masoomian, Mehdi
Berman, David M.
van der Kwast, Theodorus
Bristow, Robert G.
Kislinger, Thomas
Boutros, Paul C.
CANCER CELL, 2019, 35 (03) : 414 - +
[8] Targeted Therapy in Breast Cancer
Schneeweiss, Andreas
BREAST CARE, 2010, 5 (03) : 132 - 133
[9] Targeted therapy of breast cancer
Longo, Raffaele
Torino, Francesco
Gasparini, Giampietro
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (05) : 497 - 517
[10] Targeted Therapy of Breast Cancer
Seiffert, Katharina
Schmalfeldt, Barbara
Mueller, Volkmar
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (22) : 1669 - 1675

← 1 2 3 4 5 →